Development of a conditional self-inactivating (C-SIN) retroviral vector for liver-directed gene expression.

被引：0
|
作者：
Hwang, JJ
Kaiser, S
Anderson, WF
机构：
[1] UNIV SO CALIF,SCH MED,LOS ANGELES,CA 90089
[2] UNIV TUBINGEN,DEPT MED,D-72074 TUBINGEN,GERMANY
来源：
HEPATOLOGY | 1997年 / 26卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：267 / 267
页数：1
相关论文
共 28 条
  • [21] Liver-directed gene therapy: A retroviral vector with a complete LTR and the ApoE enhancer-alpha(1)-antitrypsin promoter dramatically increases expression of human alpha(1)-antitrypsin in vivo
    Okuyama, T
    Huber, RM
    Bowling, W
    Pearline, R
    Kennedy, SC
    Flye, MW
    Ponder, KP
    HUMAN GENE THERAPY, 1996, 7 (05) : 637 - 645
  • [22] B-cell-specific transgene expression using a self-inactivating retroviral vector with human CD19 promoter and viral post-transcriptional regulatory element
    M Werner
    J Kraunus
    C Baum
    T Brocker
    Gene Therapy, 2004, 11 : 992 - 1000
  • [23] Upstream Polyadenylation Enhancers in the U3 Region of Self-Inactivating Retroviral and Lentiviral Vectors Improve Titer and Gene Expression, and Prevent Transcriptional Read-Through
    Schambach, Axel
    Galla, Melanie
    Christopher, Baum
    MOLECULAR THERAPY, 2006, 13 : S407 - S407
  • [24] A self-inactivating lentiviral vector for SCID-X1 gene therapy that does not activate LMO2 expression in human T cells
    Zhou, Sheng
    Mody, Disha
    DeRavin, Suk See
    Hauer, Julia
    Lu, Taihe
    Ma, Zhijun
    Abina, Salima Hacein-Bey
    Gray, John T.
    Greene, Michael R.
    Cavazzana-Calvo, Marina
    Malech, Harry L.
    Sorrentino, Brian P.
    BLOOD, 2010, 116 (06) : 900 - 908
  • [25] Optimization of self-complementary AAV vectors for liver-directed expression results in sustained correction of hemophilia B at low vector dose
    Wu, Zhijian
    Sun, Junjiang
    Zhang, Taiping
    Yin, Chaoying
    Yin, Fang
    Van Dyke, Terry
    Samulski, Richard J.
    Monahan, Paul E.
    MOLECULAR THERAPY, 2008, 16 (02) : 280 - 289
  • [26] T cell responses to AAV vector capsid limit the duration of transgene expression in humans after liver-directed gene therapy.
    Mingozzi, F
    Maus, MV
    Sabatino, DE
    Hui, D
    Manno, CS
    Ragni, MV
    High, KA
    BLOOD, 2005, 106 (11) : 855A - 855A
  • [27] The cHS-4 chromatin insulator sequence protects clonal dominance of hematopoietic stem cells transduced with a self-inactivating SIV vector in platelet-directed gene therapy
    Ohmori, T.
    Madoiwa, S.
    Kashiwakura, Y.
    Ishiwata, A.
    Akiba, E.
    Hasegawa, M.
    Mimuro, J.
    Sakata, Y.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2009, 7 : 950 - 950
  • [28] Stable Expression of the Sodium/Iodide Symporter (NIS) for anti-Cancer Gene Therapy of Glioma Cells Using a Third Generation Self-Inactivating Lentiviral Vector System in Combination with At-211
    Wild, Ramona
    Korkmaz, Zekiye
    Stripecke, Renata
    Sundarasetty, Bala Sai
    Knapp, Wolfram H.
    Petrich, Thorsten
    CURRENT RADIOPHARMACEUTICALS, 2010, 3 (04) : 322 - 333
123